Immunovant, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Immunovant, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2020 to Q3 2024.
- Immunovant, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.74 USD/shares, a 64.4% decline year-over-year.
- Immunovant, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -2.2 USD/shares, a 11.7% decline year-over-year.
- Immunovant, Inc. annual Earnings Per Share, Basic for 2023 was -1.88 USD/shares, a 9.94% decline from 2022.
- Immunovant, Inc. annual Earnings Per Share, Basic for 2022 was -1.71 USD/shares, a 19.6% decline from 2021.
- Immunovant, Inc. annual Earnings Per Share, Basic for 2021 was -1.43 USD/shares, a 17.2% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)